A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)
Clinical trial NCT03030976 · UNKNOWN
Trial details
- NCT number
- NCT03030976
- Sponsor
- Shanghai GeneChem Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2018-01-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.